Increased neutrophil lifespan in patients with congestive heart failure

European Journal of Heart Failure

Volumn 11, Issue 4, 2009, Pages 378-385

  Tracchi, Irene ^a   Ghigliotti, Giorgio ^a   Mura, Marzia ^a   Garibaldi, Silvano ^a   Spallarossa, Paolo ^a   Barisione, Chiara ^a   Boasi, Valentina ^a   Brunelli, Michele ^a   Corsiglia, Luca ^b   Barsotti, Antonio ^a   Brunelli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Casa di Cura Istituto Cardiovascolare Camogli (ISC)   (Italy)

Author keywords

Apoptosis; Congestive heart failure; Endothelial apoptosis; Neutrophil apoptosis; Neutrophils

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; PROPIDIUM IODIDE;

AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENDOTHELIUM INJURY; FLOW CYTOMETRY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; KIDNEY FUNCTION TEST; LABORATORY TEST; LIVER FUNCTION TEST; NEUTROPHIL; PRIORITY JOURNAL;

AGED; APOPTOSIS; C-REACTIVE PROTEIN; CELLS, CULTURED; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; LEUKOCYTE COUNT; NEUTROPHILS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME;

EID: 66249125313     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp031     Document Type: Article

References (35)

1. Dibbs Z, Thornby J, White BG, Mann DL. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 1999;33:1935- 1942.
2. Kaneko K, Kanda T, Yamauchi Y, Hasegawa A, Iwasaki T, Arai M, Suzuki T, Kobayashi I, Nagai R. C-reactive protein in dilated cardiomyopathy. Cardiology 1999;91:215-219.
3. Baumgarten G, Knuefermann P, Mann DL Cytokines as emerging targets in the treatment of heart failure. Trends Cardiovasc Med 2000;10:216- 223.
4. Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M, Teixeira MM, Hellewell PG, Hooper J, Poole-Wilson PA, Coats AJ. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20:683-693.
5. Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996;77: 723-727.
6. Kristal B, Shurtz-Swirski R, Chezar J, Manaster J, Levy R, Shapiro G, Weissman I, Shasha SM, Sela S. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. Am J Hypertens 1998;11:921-928.
7. Altieri P, Brunelli C, Garibaldi S, Nicolino A, Ubaldi S, Spallarossa P, Olivotti L, Rossettin P, Barsotti A, Ghigliotti G. Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. Eur J Clin Invest 2003;33:648-656.
8. Garlichs CD, Eskafi S, Cicha I, Schmeisser A, Walzog B, Raaz D, Stumpf C, Yilmaz A, Bremer J, Ludwig J, Daniel WG. Delay of neutrophil apoptosis in acute coronary syndromes. J Leukoc Biol 2004;75:828-835.
9. Rumalla VK, Calvano SE, Spotnitz AJ, Krause TJ, Hilkert RJ, Lin E, Lowry SF. Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure. Ann Surg 2002;236:254-260.
10. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-1446.
11. Spallarossa P, Garibaldi S, Barisione C, Ghigliotti G, Altieri P, Tracchi I, Fabbi P, Barsotti A, Brunelli C. Postprandial serum induces apoptosis in endothelial cells: role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity. Atherosclerosis 2008; 198:458-467.
12. Rössig L, Haendeler J, Mallat Z, Hugel B, Freyssinet JM, Tedgui A, Dimmeler S, Zeiher AM. Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J Am Coll Cardiol 2000;36:2081-2089.
13. Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, Volterrani M, Bonetti P, Parrinello G, Cadei M, Grigolato PG, Ferrari R. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation 1999;100:1983- 1991.
14. Cohen JJ. Programmed cell death and apoptosis in lymphocyte development and function. Chest 1993;103(Suppl. 2):99S-101S.
15. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med 1990;323: 236-241.
16. Samsonov M, Nassonov E, Masenko V, Naumov V, Mareev V, Belenkov Y. Ana-phylatoxins in dilated cardiomyopathy. J Intern Med 1993;234:139-142.
17. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999;353:1838- 1842.
18. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulo-cyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-2020.
19. Hannah S, Mecklenburgh K, Rahman I, Bellingan GJ, Greening A, Haslett C, Chilvers ER. Hypoxia prolongs neutrophil survival in vitro. FEBS Lett 1995;372: 233-237.
20. Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dallegri F, Ottonello L, Pistoia V. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 2008;26:151-162.
21. Lee A, Whyte MK, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993;54: 283-288.
22. Taylor EL, Megson IL, Haslett C, Rossi AG. Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis. Cell Death Differ 2003;10:418-430.
23. Alonso-Martínez JL, Llorente-Diez B, Echegaray-Agara M, Olaz-Preciado F, Urbieta-Echezarreta M, González-Arencibia C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 2002;4:331 -336.
24. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, Harken AH. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 1999;27:1309-1318.
25. Khreiss T, József L, Hossain S, Chan J, Potempa LA, Filep JG. Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils.J Biol Chem 2002;77:40775-40781.
26. Rees RF, Gewurz H, Siegel JN, Coon J, Potempa LA. Expression of a C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle. Clin Immunol Immunopathol 1988;48:95-107.
27. Diehl EE, Haines GK, Radosevich JA, Potempa LA. Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue. Am J Med Sci 2000;319:79-83.
28. Lau GT, Tan HC, Krithrarides L Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002;90: 1405-1408.
29. Carr JG, Stevenson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989;63:709-713.
30. von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res 2007;73: 298-309.
31. Rudolph V, Rudolph TK, Hennings JC, Blankenberg S, Schnabel R, Steven D, Haddad M, Knittel K, Wende S, Wenzel J, Münzel T, Heitzer T, Meinertz T, Hübner C, Baldus S. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function. Free Radic Biol Med 2007;43:1189-1196.
32. Jacobi J, Sela S, Cohen HI, Chezar J, Kristal B. Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury. AmJ Physiol Heart Circ Physiol 2006;290:H2051-H2058.
33. Vanderlaan PA, Reardon CA. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res 2005;46:829-838.
34. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating levels of proin-flammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol 2005;95:452-456.
35. Coxon A, Tang T, Mayadas TN. Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo: a role for granulocyte/macrophage colony-stimulating factor. J Exp Med 1999; 90:923-934.